# Effect of Adding Human Umbilical Cord Mesenchymal Stem Cells–Derived Secretome on Sperm Quality Improvement by Swim‐Up Method

**Authors:** Binarwan Halim, Cynthia Retna Sartika, Laura Agnes Edessa Sibuea, Carine Annabella Widjaja, Diana Novia, Rima Haifa, Karina Kalasuba

PMC · DOI: 10.1155/ogi/8181670 · Obstetrics and Gynecology International · 2026-02-24

## TL;DR

This study explores how adding secretome from human umbilical cord stem cells improves sperm quality during a common lab procedure.

## Contribution

The novel use of stem cell-derived secretome to enhance sperm motility and reduce DNA fragmentation is demonstrated.

## Key findings

- Secretome addition significantly improved rapid progressive sperm motility.
- Secretome reduced sperm DNA fragmentation without affecting concentration.
- No significant differences in sperm concentration were observed between groups.

## Abstract

Suboptimal sperm quality often poses a challenge to successful fertilization. This study hypothesizes that secretome could enhance sperm quality and increase the likelihood of successful pregnancy. This research aims to assess the impact of secretome on various sperm quality parameters, including concentration, motility, and DNA fragmentation, while considering patient‐related factors such as age, duration of abstinence, and body mass index (BMI).

An analysis involving 45 patients enrolled in the pregnancy program at Halim Fertility Center, Stella Maris Women’s and Children’s Hospital, Indonesia, from April to September 2023 was conducted. Semen samples from these patients were subjected to the swim‐up method and divided into two groups: Group A, which underwent swim‐up without secretome, and Group B, which underwent swim‐up with the addition of secretome. DNA fragmentation analysis was performed on the sperm swim‐up results from both groups. The sperm analysis data obtained before swim‐up (pretreatment) with those of Group A and Group B were compared.

The demographic data revealed an average age of 37.67 ± 5.36 years, abstinence duration of 4.00 ± 1.15 days, and BMI of 28.20 ± 3.49 kg/m2 among the patients. No significant difference was observed in sperm concentration between pretreatment, Group A, and Group B (mil/mL) (36.2 ± 18.5; 36.3 ± 18.4; 36.6 ± 19.3). However, a significant difference was found in the rapid progressive motility of sperm across pretreatment, Group A, and Group B (%) (0.48 ± 1.32; 13.7 ± 8.3; 17 ± 8.3), as well as a significant reduction in DNA fragmentation in Group B compared to Group A (%) (3.48 vs. 4.39).

The findings suggest that secretome enhances rapid progressive motility and reduces DNA fragmentation rates without affecting sperm concentration.

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}
- **Diseases:** asthenozoospermia (MESH:D053627), /R (MESH:C580424), Infertility (MESH:D007246), RP (MESH:C564983), hepatitis B (MESH:D006509), hepatitis C (MESH:D019698), degenerative disorders (MESH:D019636), inflammatory (MESH:D007249), testicular damage (MESH:D013733), azoospermia (MESH:D053713), ischemia (MESH:D007511), reproductive disorders (MESH:D060737), Male factor infertility (MESH:D007248), burns (MESH:D002056), infectious diseases (MESH:D003141), cryptozoospermia (MESH:D009845), adipose (MESH:D018205), testicular torsion (MESH:D013086), type 1 diabetes mellitus (MESH:D003922)
- **Chemicals:** Busulfan (MESH:D002066), G-MOPS  PLUS (-), cisplatin (MESH:D002945), Melatonin (MESH:D008550), PUFAs (MESH:D005231), oxygen (MESH:D010100), alcohol (MESH:D000438), ROS (MESH:D017382), ATP (MESH:D000255), lipid (MESH:D008055), testosterone (MESH:D013739)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Cell lines:** AD-MSCs — Homo sapiens (Human), Somatic stem cell (CVCL_WG55), HUC — Homo sapiens (Human), Transformed cell line (CVCL_3798)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930481/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12930481/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12930481/full.md

---
Source: https://tomesphere.com/paper/PMC12930481